Structure

InChI Key ZPAKPRAICRBAOD-UHFFFAOYSA-N
Smiles O=C(O)CCC(=O)c1ccc(-c2ccccc2)cc1
InChI
InChI=1S/C16H14O3/c17-15(10-11-16(18)19)14-8-6-13(7-9-14)12-4-2-1-3-5-12/h1-9H,10-11H2,(H,18,19)

Physicochemical Descriptors

Property Name Value
Molecular Formula C16H14O3
Molecular Weight 254.28
AlogP 3.4
Hydrogen Bond Acceptor 2.0
Hydrogen Bond Donor 1.0
Number of Rotational Bond 5.0
Polar Surface Area 54.37
Molecular species ACID
Aromatic Rings 2.0
Heavy Atoms 19.0
Assay Description Organism Bioactivity Reference
Evaluated for the percentage inhibition by adjuvant arthritis test at a dose of 50 mg/kg administarted perorally Rattus norvegicus 71.0 %
Antiinflammatory activity in rat assessed as inhibition of carrageenan-induced paw edema at 10 mg/kg, po Rattus norvegicus 56.3 %
Inhibition of lipid peroxidation assessed as malondialdehyde level per 100 mg of gastric mucosa isolated from albino mouse at dose 30 mg/kg, po Mus musculus 6.8 %
Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM Cricetulus griseus 172.92 %
Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM Cricetulus griseus 86.33 %
Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of Caco-2 cells at 10 uM after 48 hours by high content imaging Homo sapiens -0.76 %
SARS-CoV-2 3CL-Pro protease inhibition percentage at 20µM by FRET kind of response from peptide substrate Severe acute respiratory syndrome coronavirus 2 12.4 %
Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging Chlorocebus sabaeus -0.1 % Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging Chlorocebus sabaeus -0.1 %

Cross References

Resources Reference
ChEBI 31599
ChEMBL CHEMBL277522
DrugBank DB08981
DrugCentral 1145
FDA SRS 9815R1WR9B
PharmGKB PA166049176
PubChem 3335
SureChEMBL SCHEMBL25117
ZINC ZINC000000001427